Efficacy and Safety of Long‐Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta‐analysis of Randomized Controlled Trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Long‐Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta‐analysis of Randomized Controlled Trials
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-03-06
DOI
10.1161/jaha.120.019184
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)
- (2020) Kevin R. Bainey et al. CIRCULATION
- Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
- (2020) Marieke Gimbel et al. LANCET
- Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis
- (2019) Jun Yuan et al. ADVANCES IN THERAPY
- Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: a Meta-analysis of Randomized Controlled Trials
- (2019) Houyong Zhu et al. CLINICAL THERAPEUTICS
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
- (2019) Deepak L Bhatt et al. LANCET
- Ticagrelor in Patients with Stable Coronary Disease and Diabetes
- (2019) P. Gabriel Steg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- (2019) Remo H M Furtado et al. EUROPEAN HEART JOURNAL
- Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)
- (2018) Rachel C. Orme et al. CIRCULATION
- Cangrelor compared with clopidogrel in patients with prior myocardial infarction – Insights from the CHAMPION trials
- (2018) Alon Eisen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Stuart J Connolly et al. LANCET
- Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial
- (2018) Jeffrey S Berger et al. VASCULAR MEDICINE
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Low-Dose Ticagrelor Versus Clopidogrel in Patients With Prior Myocardial Infarction
- (2017) Dimitrios Alexopoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
- (2017) E Magnus Ohman et al. LANCET
- Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents
- (2016) Taek Kyu Park et al. Circulation-Cardiovascular Interventions
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- The Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients with Prior Myocardial Infarction and no History of Stroke or TIA: Results from TRA 2°P-TIMI 50
- (2015) Erin A. Bohula et al. CIRCULATION
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
- (2012) Matthew T. Roe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
- (2012) J. P. T. Higgins et al. Research Synthesis Methods
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
- (2011) Sidney C. Smith et al. CIRCULATION
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Thrombus Formation
- (2008) Bruce Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now